ViiV ownership shifts as Pfizer sells its stake Pfizer will relinquish its stake in HIV firm ViiV in a deal valued at $2.1bn that ramps up Shionogi's interest and simplifies its share structure

#ViiV #Pfizer #ViiVHealthcare #Shionogi #HIV #GSK #strategicpartnership #jointventure #HIVtherapies #GileadSciences #HIVtreatment #antiretroviraltherapy #longeractinginjectableregimens #HIVpreexposureprophylaxis #PrEP #preexposureprophylaxis #Apretude #cabotegravir #lenacapavir
zurl.co/khJ6D

ViiV ownership shifts as Pfizer sells its stake Pfizer will relinquish its stake in HIV firm ViiV in a deal valued at $2.1bn that ramps up Shionogi's interest and simplifies its share structure

#Pfizer will relinquish its stake in #ViiV in a deal valued at $2.1bn that ramps up Shionogi's interest and simplifies the #HIV specialist's shareholder structure.

pharmaphorum.com/news/viiv-ow...

Palermo (Viiv): "In Italia in media 2mln di euro all’anno per iniziative su Hiv" (Adnkronos) - "Viiv è un'azienda che nasce e si sviluppa per l’Hiv", è dunque naturale, "avendo come obiettivo un'unica area terapeutica, concentrare tutti i nostri sforzi in essa. Ogni anno l’azienda investe in Italia una media d...

TI POTREBBE INTERESSARE: Palermo (Viiv): "In Italia in media 2mln di euro all’anno per iniziative su Hiv" ... LEGGI TUTTO #HIV #Salute #Viiv #Prevenzione #Ricerca

Palermo (Viiv): "In Italia in media 2mln di euro all’anno per iniziative su Hiv" (Adnkronos) - "Viiv è un'azienda che nasce e si sviluppa per l’Hiv", è dunque naturale, "avendo come obiettivo un'unica area terapeutica, concentrare tutti i nostri sforzi in essa. Ogni anno l’azienda investe in Italia una media d...

È ACCADUTO IERI: Palermo (Viiv): "In Italia in media 2mln di euro all’anno per iniziative su Hiv" ... LEGGI TUTTO #HIV #SalutePubblica #Italia #Viiv #PrevenzioneHIV

ViiV expands licensing deal for its HIV drug in low-income countries ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism.

ViiV expands licensing deal for its HIV drug in low-income countries.. statnews.com/pharmalot/20... #pharma #HIV #AIDS #medicine #PrEP #lenacapavir #patents #Gilead #GSK #ViiV

The MPP and ViiV have expanded their agreement to now include cabotegravir long-acting for both #HIV prevention and treatment.
This is the first fully long-acting HIV treatment made available through a voluntary licence in low- and middle- income countries.

#IAS2025 #ViiV #Unitaid

The corporate champions that showed up for pride this year in light of mounting pressure to abandon the LGBTQ+ community. #lgbt #lgbtq #lgbtqia #queer #pride #pridemonth #dei #diversity #thewokeginger #kaiserpermanente #usbank #delta #viiv #nordstrom #jpmorganchase #starbucks #alaskaairlines

The Drug That Could Revolutionize the Fight Against H.I.V. World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able to outpace the damage?

The Drug That Could Revolutionize the Fight Against H.I.V.
www.newyorker.com/news/the-led...
nonpaywalled: archive.fo/OF0OT

#HIV #AIDS #ViiV #ViiVhealthcare #lenacapavir #PrEP #2SLGBTQIA+

A weekend of great learning with friends and colleagues... #viiv #HIV #uequalsu

GSKとViiV、LGBTQ+支援で2つの称号を獲得！6年連続のゴールド認定 GSKとViiVがLGBTQ+に関する取り組みでPRIDE指標から6年連続でゴールドを獲得し、初めてレインボー認定を得た。多様な働き方の推進に挑む企業姿勢が評価された。

GSKとViiV、LGBTQ+支援で2つの称号を獲得！6年連続のゴールド認定 #東京都 #港区 #LGBTQ+ #GSK #ViiV

GSKとViiVがLGBTQ+に関する取り組みでPRIDE指標から6年連続でゴールドを獲得し、初めてレインボー認定を得た。多様な働き方の推進に挑む企業姿勢が評価された。